prolonging survival in patients with aml ineligible for intensive chemotherapy
Published 2 months ago • 57 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:39
optimizing chemotherapy in aml
-
1:18
an insight into the challenges in prolonging remission in aml
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:42
novel treatment combinations in aml: what’s to come?
-
1:11
genetic dynamics and factors predictive of survival in relapsed aml
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
0:56
overcoming the challenges in prolonging remission in aml
-
2:09
advances in the management of fit adults with aml
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
1:46
optimizing conditioning regimens in patients with aml undergoing allosct
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
6:16
the challenge of survivorship in aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:16
the optimization of induction chemotherapy for patients with aml
-
2:15
extending remission in patients with aml who become eligible for allosct following targeted therapy
-
2:34
the evolution of the aml treatment paradigm
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml